Form 8-K - Current report:
SEC Accession No. 0001641172-25-017288
Filing Date
2025-07-01
Accepted
2025-07-01 09:00:33
Documents
16
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38778
2 EX-10.1 ex10-1.htm EX-10.1 1589
3 EX-99.1 ex99-1.htm EX-99.1 23843
4 GRAPHIC ex10-1_001.jpg GRAPHIC 729170
5 GRAPHIC ex10-1_002.jpg GRAPHIC 1004145
  Complete submission text file 0001641172-25-017288.txt   2619786

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20250627.xsd EX-101.SCH 3059
7 XBRL LABEL FILE pcsa-20250627_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE pcsa-20250627_pre.xml EX-101.PRE 22388
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3687
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 251094293
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)